Can HbA1c Replace OGTT for the Diagnosis of Diabetes Mellitus Among Chinese Patients With IFG?
1 other identifier
observational
1,357
1 country
3
Brief Summary
This is a cross-sectional study that aims to assess the sensitivity and specificity of using HbA1c as a diagnostic test for detecting the presence of diabetes mellitus (DM) when compared to the use of oral glucose tolerance test (OGTT) among Hong Kong Chinese adult who have impaired fasting glucose (IFG). The investigators will recruit around 1000 non-diabetic adult participants who have impaired fasting glucose (i.e. fasting glucose level between 5.6 to 6.9mmol/L) AND without symptoms of hyperglycaemia to undergo both HbA1c test and oral glucose tolerance test after obtaining their informed consent. A diagnosis of DM is confirmed when both the fasting glucose level and 2-hour-post challenge plasma glucose level fall into diabetic range (i.e. fasting glucose level ≥7.0mmol/L and 2-hour-post challenge plasma glucose level ≥11.1mmol/L) after a standard 75g OGTT. Participants with only 1 plasma glucose value within the diabetic range will be invited to repeat an oral glucose tolerance test for confirmation of their diagnosis as recommended by American Diabetes Association and World Health Organization. Demographic data of the participants including age, gender, smoking status, medical history, diet and activity level will be collected. Lipid profile, blood pressure, waist circumference and body mass index will be checked and the total cardiovascular risk in 10 years will be calculated for each participant using the Joint British Societies 2005 and Framingham 2008 equations to evaluate the baseline cardiovascular risk of the participants. These data will be analyzed using SPSS. The primary outcomes are the sensitivity and specificity of HbA1c in detecting diabetes mellitus diagnosed by oral glucose tolerance test (the gold standard). A receiver operating characteristic (ROC) curve will be obtained by plotting sensitivity against (1-specificity) for each cutoff value for identification of an optimal cutoff point. Diagnostic accuracy will be assessed by the area under the curve (AUC). The differences in characteristics among participants diagnosed to have diabetes mellitus by oral glucose tolerance test or HbA1c will be compared using independent t-test or χ2 test for comparison between the 2 groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2013
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2015
CompletedFirst Submitted
Initial submission to the registry
April 23, 2015
CompletedFirst Posted
Study publicly available on registry
May 12, 2015
CompletedMarch 7, 2016
March 1, 2016
1.8 years
April 23, 2015
March 4, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The sensitivity of the use of HbA1c
The sensitivity of the use of HbA1c at different cut points for diagnosing DM among Chinese adult patients with IFG compared to OGTT as the gold standard.
around 12-16 weeks after the study completed
The specificity of the use of HbA1c
The specificity of the use of HbA1c at different cut points for diagnosing DM among Chinese adult patients with IFG compared to OGTT as the gold standard.
around 12-16 weeks after the study completed
Secondary Outcomes (5)
The optimal cut-off level of HbA1c
around 12-16 weeks after the study completed
OGTT criteria in Chinese
around 12-16 weeks after the study completed
HbA1c criteria in Chinese
around 12-16 weeks after the study completed
Cardiovascular risk
around 24-48 weeks after the study completed
DM risk
around 24-48 weeks after the study completed
Eligibility Criteria
Chinese adult subjects who are classified to have IFG will be recruited from various GOPCs from the Hong Kong West Cluster and New Territories East Cluster.
You may qualify if:
- Aged ≥ 18 year
- Chinese ethnicity
- Diagnosis of impaired fasting glucose (i.e. FG between 5.6-6.9mmol/L) identified from latest blood test results within 18 months prior to recruitment)
You may not qualify if:
- Known history of diabetes mellitus or on hypoglycaemic treatment
- Having symptoms of hyperglycaemia at recruitment
- Women who are pregnant or breast-feeding at recruitment
- Patients taking glucocorticoid at recruitment
- Active and uncontrolled thyroid diseases (including subjects on thyroid replacement therapy or anti-thyroid drugs) or active endocrine diseases such as Cushing's syndrome or Acromegaly at recruitment
- Clinically significant anaemia at recruitment
- Severe renal impairment i.e. eGFR ≤ 30 ml/min/1.73m2
- History of blood donation or blood transfusion within 3 months prior to recruitment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Chinese University of Hong Kongcollaborator
Study Sites (3)
Tsan Yuk Hospital RAMP Clinic
Hong Kong, 852, Hong Kong
Ap Lei Chau General Out-patient Clinic
Hong Kong, Hong Kong
Lek Yuen General Out-patient Clinic
Hong Kong, Hong Kong
Related Publications (2)
Guo VY, Yu EY, Wong CKh, Sit RW, Wang JH, Ho SY, Lam CL. Validation of a nomogram for predicting regression from impaired fasting glucose to normoglycaemia to facilitate clinical decision making. Fam Pract. 2016 Aug;33(4):401-7. doi: 10.1093/fampra/cmw031. Epub 2016 May 3.
PMID: 27142313DERIVEDYu EY, Wong CK, Ho SY, Wong SY, Lam CL. Can HbA1c replace OGTT for the diagnosis of diabetes mellitus among Chinese patients with impaired fasting glucose? Fam Pract. 2015 Dec;32(6):631-8. doi: 10.1093/fampra/cmv077. Epub 2015 Oct 14.
PMID: 26467644DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
YU YT Esther, Doctor
Department of Family Medicine and Primary Care, The University of Hong Kong
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2015
First Posted
May 12, 2015
Study Start
May 1, 2013
Primary Completion
March 1, 2015
Study Completion
March 1, 2015
Last Updated
March 7, 2016
Record last verified: 2016-03